{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:03:10Z","timestamp":1791237790892,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s40119-024-00395-0","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T06:35:37Z","timestamp":1735886137000},"page":"53-69","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of Social Determinants of Health on Primary Adherence of Oral Anticoagulants Among Patients with Newly Diagnosed Atrial Fibrillation"],"prefix":"10.1007","volume":"14","author":[{"given":"Nicole","family":"Glowacki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iridian","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Rebecca","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ateya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Dorscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Khatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"395_CR1","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.jacc.2020.02.025","volume":"75","author":"MK Chung","year":"2020","unstructured":"Chung MK, Refaat M, Shen WK, et al. Atrial fibrillation: JACC council perspectives. J Am Coll Cardiol. 2020;75:1689\u2013713.","journal-title":"J Am Coll Cardiol"},{"key":"395_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/clc.23983","volume":"46","author":"MP Turakhia","year":"2023","unstructured":"Turakhia MP, Guo JD, Keshishian A, et al. Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the united states. Clin Cardiol. 2023;46:484\u201393.","journal-title":"Clin Cardiol"},{"key":"395_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.amjcard.2018.04.022","volume":"122","author":"WT O'Neal","year":"2018","unstructured":"O\u2019Neal WT, Sandesara PB, Claxton JS, et al. Influence of sociodemographic factors and provider specialty on anticoagulation prescription fill patterns and outcomes in atrial fibrillation. Am J Cardiol. 2018;122:388\u201394.","journal-title":"Am J Cardiol"},{"key":"395_CR4","first-page":"1210","volume":"27","author":"A Charlton","year":"2021","unstructured":"Charlton A, Vidal X, Sabat\u00e9 M, Bailar\u00edn E, Mart\u00ednez LML, Ib\u00e1\u00f1ez L. Factors associated with primary nonadherence to newly initiated direct oral anticoagulants in patients with nonvalvular atrial fibrillation. J Manag Care Spec Pharm. 2021;27:1210\u201320.","journal-title":"J Manag Care Spec Pharm"},{"key":"395_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025102","volume":"8","author":"CL Rodr\u00edguez-Bernal","year":"2018","unstructured":"Rodr\u00edguez-Bernal CL, Garc\u00eda-Sempere A, Hurtado I, Santa-Ana Y, Peir\u00f3 S, Sanf\u00e9lix-Gimeno G. Real-world adherence to oral anticoagulants in atrial fibrillation patients: a study protocol for a systematic review and meta-analysis. BMJ Open. 2018;8:e025102.","journal-title":"BMJ Open"},{"key":"395_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/heartjnl-2019-315307","volume":"106","author":"A Banerjee","year":"2020","unstructured":"Banerjee A, Benedetto V, Gichuru P, et al. Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study. Heart. 2020;106:119\u201326.","journal-title":"Heart"},{"key":"395_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/03007995.2017.1391760","volume":"34","author":"X Xiang","year":"2018","unstructured":"Xiang X, Cao Y, Sun K, et al. Real world adherence to oral anticoagulant in non-valvular atrial fibrillation patients in china. Curr Med Res Opin. 2018;34:255\u201361.","journal-title":"Curr Med Res Opin"},{"key":"395_CR8","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/MLR.0b013e31829b1d2a","volume":"51","author":"MA Raebel","year":"2013","unstructured":"Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care. 2013;51:S11-21.","journal-title":"Med Care"},{"key":"395_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/01.mlr.0000166617.68751.5f","volume":"43","author":"R Balkrishnan","year":"2005","unstructured":"Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care. 2005;43:517\u201320.","journal-title":"Med Care"},{"key":"395_CR10","first-page":"54","volume":"8","author":"JS Lee","year":"2016","unstructured":"Lee JS, Joyce G, McCombs J. Outcomes associated with primary and secondary nonadherence to cholesterol medications. Am J Pharm Benefits. 2016;8:54\u201360.","journal-title":"Am J Pharm Benefits"},{"key":"395_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pcad.2020.08.003","volume":"64","author":"IL Pi\u00f1a","year":"2021","unstructured":"Pi\u00f1a IL, Di Palo KE, Brown MT, et al. Medication adherence: importance, issues and policy: a policy statement from the American Heart Association. Prog Cardiovasc Dis. 2021;64:111\u201320.","journal-title":"Prog Cardiovasc Dis"},{"key":"395_CR12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12265-020-10045-0","volume":"14","author":"A Padilla L\u00f3pez","year":"2021","unstructured":"Padilla L\u00f3pez A, Al\u00f3s-Almi\u00f1ana M, Peris JE. Health outcomes and primary adherence to secondary prevention treatment after ST-elevation myocardial infarction: a Spanish cohort study. J Cardiovasc Transl Res. 2021;14:308\u201316.","journal-title":"J Cardiovasc Transl Res"},{"key":"395_CR13","first-page":"125","volume":"19","author":"JN Liberman","year":"2013","unstructured":"Liberman JN, Lichtenfeld MJ, Galaznik A, et al. Adherence to varenicline and associated smoking cessation in a community-based patient setting. J Manag Care Pharm. 2013;19:125\u201331.","journal-title":"J Manag Care Pharm"},{"key":"395_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s40256-023-00588-3","volume":"23","author":"I Hernandez","year":"2023","unstructured":"Hernandez I, Divino V, Xie L, et al. A real-world evaluation of primary medication nonadherence in patients with nonvalvular atrial fibrillation prescribed oral anticoagulants in the united states. Am J Cardiovasc Drugs. 2023;23:559\u201372.","journal-title":"Am J Cardiovasc Drugs"},{"key":"395_CR15","first-page":"1400","volume":"28","author":"JS Guo","year":"2022","unstructured":"Guo JS, He M, Gabriel N, et al. Underprescribing vs underfilling to oral anticoagulation: an analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillation. J Manag Care Spec Pharm. 2022;28:1400\u20139.","journal-title":"J Manag Care Spec Pharm"},{"key":"395_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487\u201397.","journal-title":"N Engl J Med"},{"key":"395_CR17","doi-asserted-by":"publisher","first-page":"100175","DOI":"10.1016\/j.jacadv.2022.100175","volume":"2","author":"DM Tarn","year":"2023","unstructured":"Tarn DM, Shih K, Tseng C-H, Thomas A, Schwartz JB. Reasons for nonadherence to the direct oral anticoagulant apixaban. JACC Adv. 2023;2:100175.","journal-title":"JACC Adv"},{"key":"395_CR18","doi-asserted-by":"publisher","first-page":"e841","DOI":"10.1161\/CIR.0000000000000767","volume":"141","author":"C White-Williams","year":"2020","unstructured":"White-Williams C, Rossi LP, Bittner VA, et al. Addressing social determinants of health in the care of patients with heart failure: a scientific statement from the American Heart Association. Circulation. 2020;141:e841\u201363.","journal-title":"Circulation"},{"key":"395_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026745","volume":"12","author":"LM Boyd","year":"2023","unstructured":"Boyd LM, Colavecchia AC, Townsend KA, et al. Associations of community and individual social determinants of health with medication adherence in patients with atrial fibrillation: a retrospective cohort study. J Am Heart Assoc. 2023;12:e026745.","journal-title":"J Am Heart Assoc"},{"key":"395_CR20","doi-asserted-by":"crossref","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2024;149(1):e1\u2013e156.","DOI":"10.1161\/CIR.0000000000001207"},{"key":"395_CR21","first-page":"e655","volume":"21","author":"D Comer","year":"2015","unstructured":"Comer D, Couto J, Aguiar R, Wu P, Elliott D. Using aggregated pharmacy claims to identify primary nonadherence. Am J Manag Care. 2015;21:e655-660.","journal-title":"Am J Manag Care"},{"key":"395_CR22","first-page":"1482","volume":"27","author":"S Blecker","year":"2021","unstructured":"Blecker S, Adhikari S, Zhang H, et al. Validation of EHR medication fill data obtained through electronic linkage with pharmacies. J Manag Care Spec Pharm. 2021;27:1482\u20137.","journal-title":"J Manag Care Spec Pharm"},{"key":"395_CR23","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12:1495\u20139.","journal-title":"Int J Surg"},{"key":"395_CR24","unstructured":"Surescripts L. 2022 National progress report: tracking the impact of health intelligence sharing across the US. 2023. https:\/\/surescripts.widen.net\/s\/mvtqvvf5sd\/2022-national-progress-report"},{"key":"395_CR25","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1161\/CIRCULATIONAHA.111.060061","volume":"126","author":"DA Lane","year":"2012","unstructured":"Lane DA, Lip GY. Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation. Circulation. 2012;126:860\u20135.","journal-title":"Circulation"},{"key":"395_CR26","first-page":"516","volume":"22","author":"AJ Adams","year":"2016","unstructured":"Adams AJ, Stolpe SF. Defining and measuring primary medication nonadherence: development of a quality measure. J Manag Care Spec Pharm. 2016;22:516\u201323.","journal-title":"J Manag Care Spec Pharm"},{"key":"395_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027662","volume":"11","author":"A Mukhopadhyay","year":"2022","unstructured":"Mukhopadhyay A, Adhikari S, Li X, et al. Association between copayment amount and filling of medications for angiotensin receptor neprilysin inhibitors in patients with heart failure. J Am Heart Assoc. 2022;11:e027662.","journal-title":"J Am Heart Assoc"},{"key":"395_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.119.005969","volume":"13","author":"AF Ozaki","year":"2020","unstructured":"Ozaki AF, Choi AS, Le QT, et al. Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2020;13:e005969.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"395_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104718","volume":"29","author":"YG Tedla","year":"2020","unstructured":"Tedla YG, Schwartz SM, Silberman P, Greenland P, Passman RS. Racial disparity in the prescription of anticoagulants and risk of stroke and bleeding in atrial fibrillation patients. J Stroke Cerebrovasc Dis. 2020;29:104718.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"395_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/096228029900800102","volume":"8","author":"JL Schafer","year":"1999","unstructured":"Schafer JL. Multiple imputation: a primer. Stat Methods Med Res. 1999;8:3\u201315.","journal-title":"Stat Methods Med Res"},{"key":"395_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0289708","volume":"18","author":"R Khatib","year":"2023","unstructured":"Khatib R, Glowacki N, Colavecchia C, et al. Associations between clinical and social factors and anticoagulant prescription among patients with atrial fibrillation: a retrospective cohort study from a large healthcare system. PLoS ONE. 2023;18:e0289708.","journal-title":"PLoS ONE"},{"key":"395_CR32","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H, et al. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons. Circulation. 2019;140:e125\u201351.","journal-title":"Circulation"},{"key":"395_CR33","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/europace\/euv421","volume":"18","author":"J Beyer-Westendorf","year":"2016","unstructured":"Beyer-Westendorf J, Ehlken B, Evers T. Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation. Europace. 2016;18:1150\u20137.","journal-title":"Europace"},{"key":"395_CR34","first-page":"807","volume":"13","author":"SV Garkina","year":"2016","unstructured":"Garkina SV, Vavilova TV, Lebedev DS, Mikhaylov EN. Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants. J Geriatr Cardiol. 2016;13:807\u201310.","journal-title":"J Geriatr Cardiol"},{"key":"395_CR35","first-page":"e1","volume":"22","author":"S Kachroo","year":"2016","unstructured":"Kachroo S, Hamilton M, Liu X, et al. Oral anticoagulant discontinuation in patients with nonvalvular atrial fibrillation. Am J Manag Care. 2016;22:e1-8.","journal-title":"Am J Manag Care"},{"key":"395_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1001\/2013.jamainternmed.717","volume":"173","author":"SF Derose","year":"2013","unstructured":"Derose SF, Green K, Marrett E, et al. Automated outreach to increase primary adherence to cholesterol-lowering medications. JAMA Intern Med. 2013;173:38\u201343.","journal-title":"JAMA Intern Med"},{"key":"395_CR37","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/jac5.1108","volume":"2","author":"DBMA Lash","year":"2019","unstructured":"Lash DBMA, Jolliff J, Plunkett J, Joson J. Meds-to-beds: the impact of a bedside medication delivery program on 30-day readmissions. J Am Coll Clin Pharm. 2019;2:674\u201380.","journal-title":"J Am Coll Clin Pharm"},{"key":"395_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-157-1-201207030-00003","volume":"157","author":"S Kripalani","year":"2012","unstructured":"Kripalani S, Roumie CL, Dalal AK, et al. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012;157:1\u201310.","journal-title":"Ann Intern Med"},{"key":"395_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/jhm.2446","volume":"11","author":"K Wooldridge","year":"2016","unstructured":"Wooldridge K, Schnipper JL, Goggins K, Dittus RS, Kripalani S. Refractory primary medication nonadherence: prevalence and predictors after pharmacist counseling at hospital discharge. J Hosp Med. 2016;11:48\u201351.","journal-title":"J Hosp Med"},{"key":"395_CR40","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023048","volume":"11","author":"PA Noseworthy","year":"2022","unstructured":"Noseworthy PA, Branda ME, Kunneman M, et al. Effect of shared decision-making for stroke prevention on treatment adherence and safety outcomes in patients with atrial fibrillation: a randomized clinical trial. J Am Heart Assoc. 2022;11:e023048.","journal-title":"J Am Heart Assoc"},{"key":"395_CR41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev-pharmtox-010818-021348","volume":"59","author":"LL Zullig","year":"2019","unstructured":"Zullig LL, Deschodt M, Liska J, Bosworth HB, De Geest S. Moving from the trial to the real world: improving medication adherence using insights of implementation science. Annu Rev Pharmacol Toxicol. 2019;59:423\u201345.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"395_CR42","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1161\/CIR.0000000000001096","volume":"146","author":"N Moise","year":"2022","unstructured":"Moise N, Cen\u00e9 CW, Tabak RG, et al. Leveraging implementation science for cardiovascular health equity: a scientific statement from the American Heart Association. Circulation. 2022;146:e260\u201378.","journal-title":"Circulation"},{"key":"395_CR43","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1161\/CIR.0000000000001096","volume":"146","author":"N Moise","year":"2022","unstructured":"Moise N, Cene CW, Tabak RG, et al. Leveraging implementation science for cardiovascular health equity: a scientific statement from the American Heart Association. Circulation. 2022;146:e260\u201378.","journal-title":"Circulation"},{"key":"395_CR44","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027099","volume":"11","author":"D Osula","year":"2022","unstructured":"Osula D, Wu B, Schesing K, et al. Comparison of pharmacy refill data with chemical adherence testing in assessing medication nonadherence in a safety net hospital setting. J Am Heart Assoc. 2022;11:e027099.","journal-title":"J Am Heart Assoc"},{"key":"395_CR45","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.3390\/ijerph20053825","volume":"20","author":"E Olmastroni","year":"2023","unstructured":"Olmastroni E, Galimberti F, Tragni E, Catapano AL, Casula M. Impact of COVID-19 pandemic on adherence to chronic therapies: a systematic review. Int J Environ Res Public Health. 2023;20:3825.","journal-title":"Int J Environ Res Public Health"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-024-00395-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-024-00395-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-024-00395-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T16:59:45Z","timestamp":1741625985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-024-00395-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["395"],"URL":"https:\/\/doi.org\/10.1007\/s40119-024-00395-0","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J. Rebecca Mills, Ann Parks, Mohammad Ateya, and Feng Dai are employees of Pfizer. Nicole Glowacki, Iridian Guzman, Holly Dorscheid, and Rasha Khatib have no conflicts to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Advocate Aurora Health Institutional Review Board (22.193ET), which waived consent for this retrospective limited dataset and was conducted in accordance with the Helsinki Declaration of 1964. Permission was obtained to access and use data collected from the systems database.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}